OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 08/24/2026 14:36
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization299,572 mln
Float1,856 mln
Earnings Date10/27/2026
EPS
6.62
Strong
P / E
24.21
Premium valuation
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.7
Likely reliable
Relative Strength
72
/ 100
Outperforming
Debt / Equity
1.18
Elevated leverage
Business Description
Novartis AG is a Swiss pharmaceutical company founded in 1996 and based in Basel, with operations spanning dozens of countries worldwide. The company researches, develops, and sells a broad range of medicines targeting serious conditions such as heart disease, cancer, immune disorders, and neurological conditions. Its product lineup includes well-known treatments like Entresto for heart failure, Cosentyx for inflammatory diseases, Kisqali for certain cancers, and Zolgensma for spinal muscular atrophy, among many others.
